Availability of Draft National Toxicology Program Technical Reports; Request for Comments; Notice of Meeting, 15135-15136 [2014-05895]

Download as PDF Federal Register / Vol. 79, No. 52 / Tuesday, March 18, 2014 / Notices and Treatment of HIV-Related Heart, Lung and Blood Diseases. Date: April 18, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Crystal Gateway Marriott 1700 Jefferson Davis Highway Arlington, VA 22202. Contact Person: Tony L Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892–7924, 301–435– 0725, creazzotl@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS). Dated: March 11, 2014. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–05868 Filed 3–17–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, April 02, 2014, 01:00 p.m. to April 02, 2014, 03:00 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on March 11, 2014, 79 FR 13660. The meeting will be held on April 7, 2014, starting at 02:00 p.m. and ending at 03:30 p.m. The meeting location remains the same. The meeting is closed to the public. hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Heart, Lung, and Blood Advisory Council. Date: April 15, 2014. Open: 6:00 p.m. to 9:00 p.m. Agenda: Continue the February Council meeting discussion on programmatic issues. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Room 9100, Bethesda, MD 20817. Contact Person: Stephen C. Mockrin, Ph.D. Director, Division of Extramural Research Activities National Heart, Lung, and Blood Institute National Institutes of Health, 6701 Rockledge Drive, Room 7100, Bethesda, MD 20892 (301) 435–0260, mockrins@ nhlbi.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Visitors will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: www.nhlbi.nih.gov/meetings/nhlbac/ index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS). Dated: March 11, 2014. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. Dated: March 11, 2014. Michelle Trout, Program Officer, Office of Federal Advisory Committee Policy. [FR Doc. 2014–05869 Filed 3–17–14; 8:45 am] [FR Doc. 2014–05870 Filed 3–17–14; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P emcdonald on DSK67QTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is Availability of Draft National Toxicology Program Technical Reports; Request for Comments; Notice of Meeting SUMMARY: VerDate Mar<15>2010 18:34 Mar 17, 2014 Jkt 232001 The National Toxicology Program (NTP) announces the PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 15135 availability of four draft NTP Technical Reports (TRs) scheduled for peer review: bromodichloroacetic acid, CIMSTAR 3800, green tea extract, and indole-3-carbinol. The peer-review meeting is open to the public. Registration is requested for both public attendance and oral comment and required to access the webcast. Information about the meeting and registration are available at https:// ntp.niehs.nih.gov/go/36051. DATES: Meeting: May 22, 2014, 8:30 a.m. to approximately 5:00 p.m. Eastern Daylight Time (EDT). Document Availability: Draft TRs should be available by April 10, 2014, at https://ntp.niehs.nih.gov/go/36051. Written Public Comment Submissions: Deadline is May 8, 2014. Registration for Meeting, Oral Comments, and/or to View Webcast: Deadline is May 15, 2014. Registration to view the meeting via the webcast is required. ADDRESSES: Meeting Location: Rodbell Auditorium, Rall Building, NIEHS, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709. Meeting Web page: The draft TRs, preliminary agenda, registration, and other meeting materials are at https:// ntp.niehs.nih.gov/go/36051. Webcast: The URL for viewing webcast will be provided to those who register. FOR FURTHER INFORMATION CONTACT: Dr. Yun Xie, NTP Designated Federal Official, Office of Liaison, Policy and Review, DNTP, NIEHS, P.O. Box 12233, MD K2–03, Research Triangle Park, NC 27709. Phone: (919) 541–3436, Fax: (301) 451–5455, Email: yun.xie@nih.gov. Hand Delivery/Courier: 530 Davis Drive, Room 2161, Morrisville, NC 27560. SUPPLEMENTARY INFORMATION: Meeting and Registration: The meeting is open to the public with time set aside for oral public comment; attendance at the NIEHS is limited only by the space available. Registration to attend the meeting in-person, provide oral comments, and/or view webcast is by May 15, 2014, at https:// ntp.niehs.nih.gov/go/36051. Registration is required to view the webcast; the URL for the webcast will be provided in the email confirming registration. Visitor and security information for those attending in-person is available at https://www.niehs.nih.gov/about/ visiting/index.cfm. Individuals with disabilities who need accommodation to participate in this event should contact Dr. Yun Xie at phone: (919) 541–3436 or email: yun.xie@nih.gov. TTY users should contact the Federal TTY Relay E:\FR\FM\18MRN1.SGM 18MRN1 emcdonald on DSK67QTVN1PROD with NOTICES 15136 Federal Register / Vol. 79, No. 52 / Tuesday, March 18, 2014 / Notices Service at (800) 877–8339. Requests should be made at least five business days in advance of the event. The preliminary agenda and draft TRs should be posted on the NTP Web site (https://ntp.niehs.nih.gov/go/36051) by April 10, 2014. Additional information will be posted when available or may be requested in hardcopy, see FOR FURTHER INFORMATION CONTACT. Following the meeting, a report of the peer review will be prepared and made available on the NTP Web site. Registered attendees are encouraged to access the meeting Web page to stay abreast of the most current information. Request for Comments: The NTP invites written and oral public comments on the draft TRs. The deadline for submission of written comments is May 8, 2014, to enable review by the peer-review panel and NTP staff prior to the meeting. Registration to provide oral comments is by May 15, 2014, at https:// ntp.niehs.nih.gov/go/36051. Public comments and any other correspondence on the draft TRs should be sent to the FOR FURTHER INFORMATION CONTACT. Persons submitting written comments should include their name, affiliation, mailing address, phone, email, and sponsoring organization (if any) with the document. Written comments received in response to this notice will be posted on the NTP Web site, and the submitter will be identified by name, affiliation, and/or sponsoring organization. Public comment at this meeting is welcome, with time set aside for the presentation of oral comments on the draft TRs. In addition to in-person oral comments at the NIEHS, public comments can be presented by teleconference line. There will be 50 lines for this call; availability is on a first-come, first-served basis. The lines will be open from 8:30 a.m. until approximately 5:00 p.m. EDT on May 22, 2014, although oral comments will be received only during the formal public comment periods indicated on the preliminary agenda. The access number for the teleconference line will be provided to registrants by email prior to the meeting. Each organization is allowed one time slot per draft TR. At least 7 minutes will be allotted to each time slot, and if time permits, may be extended to 10 minutes at the discretion of the chair. Persons wishing to make an oral presentation are asked to register online at https://ntp.niehs.nih.gov/go/36051 by May 15, 2014, indicate whether they will present comments in-person or via the teleconference line, and indicate the TR(s) on which they plan to comment. VerDate Mar<15>2010 18:34 Mar 17, 2014 Jkt 232001 If possible, oral public commenters should send a copy of their slides and/ or statement or talking points at that time. Written statements can supplement and may expand the oral presentation. Registration for in-person oral comments will also be available at the meeting, although time allowed for presentation by on-site registrants may be less than that for registered speakers and will be determined by the number of speakers who register on-site. Background Information on NTP PeerReview Panels: NTP panels are technical, scientific advisory bodies established on an ‘‘as needed’’ basis to provide independent scientific peer review and advise the NTP on agents of public health concern, new/revised toxicological test methods, or other issues. These panels help ensure transparent, unbiased, and scientifically rigorous input to the program for its use in making credible decisions about human hazard, setting research and testing priorities, and providing information to regulatory agencies about alternative methods for toxicity screening. The NTP welcomes nominations of scientific experts for upcoming panels. Scientists interested in serving on an NTP panel should provide current curriculum vitae to the FOR FURTHER INFORMATION CONTACT. The authority for NTP panels is provided by 42 U.S.C. 217a; section 222 of the Public Health Service (PHS) Act, as amended. The panel is governed by the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Dated: March 10, 2014. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2014–05895 Filed 3–17–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Start-Up Exclusive Patent License Agreement: Treatment of Breast Cancer, Prostate Cancer, Ewing Sarcoma, and Thymoma AGENCY: National Institutes of Health, HHS. ACTION: Notice. This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human SUMMARY: PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Services, is contemplating the grant of a Start-Up Exclusive Patent License Agreement to Paris Therapeutics, a company having a place of business in Santee, CA, to practice the inventions embodied in the following patent applications: 1. U.S. Provisional Patent Application. No. 61/474,664, filed April 12, 2011; HHS Ref. No.: E–068–2011/0– US–01; Titled: Human Monoclonal Antibodies that bind insulin-like growth factor (IGF) I and II; Inventors: Dimiter S. Dimitrov (NCI), Qi Zhao (NCI), and Zhongyu Zhu (NCI) 2. PCT Application No. PCT/US2012/ 033128, filed April 11, 2012; HHS Ref. No.: E–068–2011/0–PCT–02; Titled: Human Monoclonal Antibodies that bind insulin-like growth factor (IGF) I and II; Inventors: Dimiter S. Dimitrov (NCI), Qi Zhao (NCI), and Zhongyu Zhu (NCI) 3. U.S. Patent Application No. 14/ 111,507, filed October 11, 2013; HHS Ref. No.: E–068–2011/0–US– 03; Titled: Human Monoclonal Antibodies that bind insulin-like growth factor (IGF) I and II; Inventors: Dimiter S. Dimitrov (NCI), Qi Zhao (NCI), and Zhongyu Zhu (NCI) The patent rights in these inventions have been assigned to the Government of the United States of America. The territory of the prospective Start-Up Exclusive Patent License Agreement may be worldwide, and the field of use may be limited to ‘‘Antibodies against Insulin-like Growth Factors IGF–I and IGF–II for the treatment of breast cancer, prostate cancer, Ewing sarcoma, and thymoma.’’ DATES: Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before April 2, 2014 will be considered. ADDRESSES: Requests for copies of the patent application(s), inquiries, comments, and other materials relating to the contemplated Start-Up Exclusive Patent License Agreement should be directed to: Whitney A. Hastings, Ph.D., Licensing and Patenting Manager, Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852–3804; Telephone: (301) 451– 7337; Facsimile: (301) 402–0220; Email: hastingw@mail.nih.gov. A signed confidentiality nondisclosure agreement will be required to receive copies of any patent applications that have not been published or issued by the United States Patent and Trademark Office or the E:\FR\FM\18MRN1.SGM 18MRN1

Agencies

[Federal Register Volume 79, Number 52 (Tuesday, March 18, 2014)]
[Notices]
[Pages 15135-15136]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05895]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Availability of Draft National Toxicology Program Technical 
Reports; Request for Comments; Notice of Meeting

SUMMARY: The National Toxicology Program (NTP) announces the 
availability of four draft NTP Technical Reports (TRs) scheduled for 
peer review: bromodichloroacetic acid, CIMSTAR 3800, green tea extract, 
and indole-3-carbinol. The peer-review meeting is open to the public. 
Registration is requested for both public attendance and oral comment 
and required to access the webcast. Information about the meeting and 
registration are available at https://ntp.niehs.nih.gov/go/36051.

DATES: Meeting: May 22, 2014, 8:30 a.m. to approximately 5:00 p.m. 
Eastern Daylight Time (EDT).
    Document Availability: Draft TRs should be available by April 10, 
2014, at https://ntp.niehs.nih.gov/go/36051.
    Written Public Comment Submissions: Deadline is May 8, 2014.
    Registration for Meeting, Oral Comments, and/or to View Webcast: 
Deadline is May 15, 2014. Registration to view the meeting via the 
webcast is required.

ADDRESSES:
    Meeting Location: Rodbell Auditorium, Rall Building, NIEHS, 111 
T.W. Alexander Drive, Research Triangle Park, NC 27709.
    Meeting Web page: The draft TRs, preliminary agenda, registration, 
and other meeting materials are at https://ntp.niehs.nih.gov/go/36051.
    Webcast: The URL for viewing webcast will be provided to those who 
register.

FOR FURTHER INFORMATION CONTACT: Dr. Yun Xie, NTP Designated Federal 
Official, Office of Liaison, Policy and Review, DNTP, NIEHS, P.O. Box 
12233, MD K2-03, Research Triangle Park, NC 27709. Phone: (919) 541-
3436, Fax: (301) 451-5455, Email: yun.xie@nih.gov. Hand Delivery/
Courier: 530 Davis Drive, Room 2161, Morrisville, NC 27560.

SUPPLEMENTARY INFORMATION:
    Meeting and Registration: The meeting is open to the public with 
time set aside for oral public comment; attendance at the NIEHS is 
limited only by the space available. Registration to attend the meeting 
in-person, provide oral comments, and/or view webcast is by May 15, 
2014, at https://ntp.niehs.nih.gov/go/36051. Registration is required to 
view the webcast; the URL for the webcast will be provided in the email 
confirming registration. Visitor and security information for those 
attending in-person is available at  https://www.niehs.nih.gov/about/visiting/index.cfm. Individuals with disabilities who need 
accommodation to participate in this event should contact Dr. Yun Xie 
at phone: (919) 541-3436 or email: yun.xie@nih.gov. TTY users should 
contact the Federal TTY Relay

[[Page 15136]]

Service at (800) 877-8339. Requests should be made at least five 
business days in advance of the event.
    The preliminary agenda and draft TRs should be posted on the NTP 
Web site (https://ntp.niehs.nih.gov/go/36051) by April 10, 2014. 
Additional information will be posted when available or may be 
requested in hardcopy, see FOR FURTHER INFORMATION CONTACT. Following 
the meeting, a report of the peer review will be prepared and made 
available on the NTP Web site. Registered attendees are encouraged to 
access the meeting Web page to stay abreast of the most current 
information.
    Request for Comments: The NTP invites written and oral public 
comments on the draft TRs. The deadline for submission of written 
comments is May 8, 2014, to enable review by the peer-review panel and 
NTP staff prior to the meeting. Registration to provide oral comments 
is by May 15, 2014, at https://ntp.niehs.nih.gov/go/36051. Public 
comments and any other correspondence on the draft TRs should be sent 
to the FOR FURTHER INFORMATION CONTACT. Persons submitting written 
comments should include their name, affiliation, mailing address, 
phone, email, and sponsoring organization (if any) with the document. 
Written comments received in response to this notice will be posted on 
the NTP Web site, and the submitter will be identified by name, 
affiliation, and/or sponsoring organization.
    Public comment at this meeting is welcome, with time set aside for 
the presentation of oral comments on the draft TRs. In addition to in-
person oral comments at the NIEHS, public comments can be presented by 
teleconference line. There will be 50 lines for this call; availability 
is on a first-come, first-served basis. The lines will be open from 
8:30 a.m. until approximately 5:00 p.m. EDT on May 22, 2014, although 
oral comments will be received only during the formal public comment 
periods indicated on the preliminary agenda. The access number for the 
teleconference line will be provided to registrants by email prior to 
the meeting. Each organization is allowed one time slot per draft TR. 
At least 7 minutes will be allotted to each time slot, and if time 
permits, may be extended to 10 minutes at the discretion of the chair.
    Persons wishing to make an oral presentation are asked to register 
online at https://ntp.niehs.nih.gov/go/36051 by May 15, 2014, indicate 
whether they will present comments in-person or via the teleconference 
line, and indicate the TR(s) on which they plan to comment. If 
possible, oral public commenters should send a copy of their slides 
and/or statement or talking points at that time. Written statements can 
supplement and may expand the oral presentation. Registration for in-
person oral comments will also be available at the meeting, although 
time allowed for presentation by on-site registrants may be less than 
that for registered speakers and will be determined by the number of 
speakers who register on-site.
    Background Information on NTP Peer-Review Panels: NTP panels are 
technical, scientific advisory bodies established on an ``as needed'' 
basis to provide independent scientific peer review and advise the NTP 
on agents of public health concern, new/revised toxicological test 
methods, or other issues. These panels help ensure transparent, 
unbiased, and scientifically rigorous input to the program for its use 
in making credible decisions about human hazard, setting research and 
testing priorities, and providing information to regulatory agencies 
about alternative methods for toxicity screening. The NTP welcomes 
nominations of scientific experts for upcoming panels. Scientists 
interested in serving on an NTP panel should provide current curriculum 
vitae to the FOR FURTHER INFORMATION CONTACT. The authority for NTP 
panels is provided by 42 U.S.C. 217a; section 222 of the Public Health 
Service (PHS) Act, as amended. The panel is governed by the Federal 
Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which sets 
forth standards for the formation and use of advisory committees.

    Dated: March 10, 2014.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2014-05895 Filed 3-17-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.